nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP3A4—Temozolomide—melanoma	0.133	0.385	CbGbCtD
Hydromorphone—CYP2D6—Vemurafenib—melanoma	0.114	0.332	CbGbCtD
Hydromorphone—CYP3A4—Vemurafenib—melanoma	0.0726	0.211	CbGbCtD
Hydromorphone—CYP3A4—Docetaxel—melanoma	0.0249	0.0724	CbGbCtD
Hydromorphone—Naloxone—TLR4—melanoma	0.00484	0.628	CrCbGaD
Hydromorphone—Lethargy—Docetaxel—melanoma	0.00094	0.00231	CcSEcCtD
Hydromorphone—Urethral disorder—Temozolomide—melanoma	0.000939	0.00231	CcSEcCtD
Hydromorphone—Eye disorder—Carmustine—melanoma	0.000926	0.00228	CcSEcCtD
Hydromorphone—Hyponatraemia—Docetaxel—melanoma	0.000924	0.00227	CcSEcCtD
Hydromorphone—Visual impairment—Temozolomide—melanoma	0.000923	0.00227	CcSEcCtD
Hydromorphone—Erythema—Dactinomycin—melanoma	0.000922	0.00227	CcSEcCtD
Hydromorphone—Pain in extremity—Docetaxel—melanoma	0.000921	0.00226	CcSEcCtD
Hydromorphone—Flushing—Carmustine—melanoma	0.00092	0.00226	CcSEcCtD
Hydromorphone—Ill-defined disorder—Bleomycin—melanoma	0.000917	0.00226	CcSEcCtD
Hydromorphone—Diarrhoea—Vemurafenib—melanoma	0.000911	0.00224	CcSEcCtD
Hydromorphone—Migraine—Docetaxel—melanoma	0.000906	0.00223	CcSEcCtD
Hydromorphone—Eye disorder—Temozolomide—melanoma	0.000895	0.0022	CcSEcCtD
Hydromorphone—Tinnitus—Temozolomide—melanoma	0.000893	0.0022	CcSEcCtD
Hydromorphone—Malaise—Bleomycin—melanoma	0.000891	0.00219	CcSEcCtD
Hydromorphone—Flushing—Temozolomide—melanoma	0.000889	0.00219	CcSEcCtD
Hydromorphone—Cardiac disorder—Temozolomide—melanoma	0.000889	0.00219	CcSEcCtD
Hydromorphone—Arrhythmia—Carmustine—melanoma	0.000885	0.00218	CcSEcCtD
Hydromorphone—Leukopenia—Bleomycin—melanoma	0.000885	0.00218	CcSEcCtD
Hydromorphone—Dizziness—Vemurafenib—melanoma	0.000881	0.00217	CcSEcCtD
Hydromorphone—Angiopathy—Temozolomide—melanoma	0.000869	0.00214	CcSEcCtD
Hydromorphone—Mental disorder—Carmustine—melanoma	0.000868	0.00214	CcSEcCtD
Hydromorphone—Immune system disorder—Temozolomide—melanoma	0.000865	0.00213	CcSEcCtD
Hydromorphone—Mediastinal disorder—Temozolomide—melanoma	0.000863	0.00212	CcSEcCtD
Hydromorphone—Malnutrition—Carmustine—melanoma	0.000863	0.00212	CcSEcCtD
Hydromorphone—Erythema—Carmustine—melanoma	0.000863	0.00212	CcSEcCtD
Hydromorphone—Cough—Bleomycin—melanoma	0.000863	0.00212	CcSEcCtD
Hydromorphone—Chills—Temozolomide—melanoma	0.000859	0.00211	CcSEcCtD
Hydromorphone—Dehydration—Docetaxel—melanoma	0.000856	0.00211	CcSEcCtD
Hydromorphone—Ill-defined disorder—Dactinomycin—melanoma	0.000855	0.0021	CcSEcCtD
Hydromorphone—Vomiting—Vemurafenib—melanoma	0.000847	0.00208	CcSEcCtD
Hydromorphone—Chest pain—Bleomycin—melanoma	0.000842	0.00207	CcSEcCtD
Hydromorphone—Myalgia—Bleomycin—melanoma	0.000842	0.00207	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Docetaxel—melanoma	0.000841	0.00207	CcSEcCtD
Hydromorphone—Abdominal pain upper—Docetaxel—melanoma	0.000841	0.00207	CcSEcCtD
Hydromorphone—Rash—Vemurafenib—melanoma	0.00084	0.00206	CcSEcCtD
Hydromorphone—Mental disorder—Temozolomide—melanoma	0.000839	0.00206	CcSEcCtD
Hydromorphone—Dermatitis—Vemurafenib—melanoma	0.000839	0.00206	CcSEcCtD
Hydromorphone—Back pain—Carmustine—melanoma	0.000835	0.00205	CcSEcCtD
Hydromorphone—Headache—Vemurafenib—melanoma	0.000834	0.00205	CcSEcCtD
Hydromorphone—Erythema—Temozolomide—melanoma	0.000834	0.00205	CcSEcCtD
Hydromorphone—Malnutrition—Temozolomide—melanoma	0.000834	0.00205	CcSEcCtD
Hydromorphone—Breast disorder—Docetaxel—melanoma	0.000832	0.00205	CcSEcCtD
Hydromorphone—Discomfort—Bleomycin—melanoma	0.000831	0.00204	CcSEcCtD
Hydromorphone—Malaise—Dactinomycin—melanoma	0.000831	0.00204	CcSEcCtD
Hydromorphone—Cramp muscle—Docetaxel—melanoma	0.000829	0.00204	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000829	0.00204	CcSEcCtD
Hydromorphone—Leukopenia—Dactinomycin—melanoma	0.000825	0.00203	CcSEcCtD
Hydromorphone—Nasopharyngitis—Docetaxel—melanoma	0.000823	0.00202	CcSEcCtD
Hydromorphone—Dysgeusia—Temozolomide—melanoma	0.000817	0.00201	CcSEcCtD
Hydromorphone—Confusional state—Bleomycin—melanoma	0.000813	0.002	CcSEcCtD
Hydromorphone—Vision blurred—Carmustine—melanoma	0.000813	0.002	CcSEcCtD
Hydromorphone—Tremor—Carmustine—melanoma	0.000808	0.00199	CcSEcCtD
Hydromorphone—Anaphylactic shock—Bleomycin—melanoma	0.000807	0.00198	CcSEcCtD
Hydromorphone—Back pain—Temozolomide—melanoma	0.000807	0.00198	CcSEcCtD
Hydromorphone—Infection—Bleomycin—melanoma	0.000801	0.00197	CcSEcCtD
Hydromorphone—Dysphagia—Docetaxel—melanoma	0.000796	0.00196	CcSEcCtD
Hydromorphone—Agitation—Carmustine—melanoma	0.000793	0.00195	CcSEcCtD
Hydromorphone—Naltrexone—ABCB1—melanoma	0.000791	0.103	CrCbGaD
Hydromorphone—Nausea—Vemurafenib—melanoma	0.000791	0.00194	CcSEcCtD
Hydromorphone—Vision blurred—Temozolomide—melanoma	0.000786	0.00193	CcSEcCtD
Hydromorphone—Myalgia—Dactinomycin—melanoma	0.000785	0.00193	CcSEcCtD
Hydromorphone—Bronchospasm—Docetaxel—melanoma	0.000783	0.00192	CcSEcCtD
Hydromorphone—Tremor—Temozolomide—melanoma	0.000781	0.00192	CcSEcCtD
Hydromorphone—Discomfort—Dactinomycin—melanoma	0.000775	0.00191	CcSEcCtD
Hydromorphone—Ill-defined disorder—Temozolomide—melanoma	0.000774	0.0019	CcSEcCtD
Hydromorphone—Leukopenia—Carmustine—melanoma	0.000772	0.0019	CcSEcCtD
Hydromorphone—Anorexia—Bleomycin—melanoma	0.000769	0.00189	CcSEcCtD
Hydromorphone—Agitation—Temozolomide—melanoma	0.000766	0.00188	CcSEcCtD
Hydromorphone—Angioedema—Temozolomide—melanoma	0.000762	0.00187	CcSEcCtD
Hydromorphone—Hypotension—Bleomycin—melanoma	0.000754	0.00185	CcSEcCtD
Hydromorphone—Malaise—Temozolomide—melanoma	0.000752	0.00185	CcSEcCtD
Hydromorphone—Vertigo—Temozolomide—melanoma	0.000749	0.00184	CcSEcCtD
Hydromorphone—Convulsion—Carmustine—melanoma	0.000748	0.00184	CcSEcCtD
Hydromorphone—Infection—Dactinomycin—melanoma	0.000747	0.00184	CcSEcCtD
Hydromorphone—Leukopenia—Temozolomide—melanoma	0.000746	0.00184	CcSEcCtD
Hydromorphone—Hypertension—Carmustine—melanoma	0.000745	0.00183	CcSEcCtD
Hydromorphone—Palpitations—Temozolomide—melanoma	0.000737	0.00181	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000735	0.00181	CcSEcCtD
Hydromorphone—Chest pain—Carmustine—melanoma	0.000735	0.00181	CcSEcCtD
Hydromorphone—Myalgia—Carmustine—melanoma	0.000735	0.00181	CcSEcCtD
Hydromorphone—Anxiety—Carmustine—melanoma	0.000732	0.0018	CcSEcCtD
Hydromorphone—Cough—Temozolomide—melanoma	0.000728	0.00179	CcSEcCtD
Hydromorphone—Paraesthesia—Bleomycin—melanoma	0.000724	0.00178	CcSEcCtD
Hydromorphone—Convulsion—Temozolomide—melanoma	0.000722	0.00178	CcSEcCtD
Hydromorphone—Weight decreased—Docetaxel—melanoma	0.00072	0.00177	CcSEcCtD
Hydromorphone—Hypertension—Temozolomide—melanoma	0.00072	0.00177	CcSEcCtD
Hydromorphone—Dyspnoea—Bleomycin—melanoma	0.000719	0.00177	CcSEcCtD
Hydromorphone—Anorexia—Dactinomycin—melanoma	0.000717	0.00176	CcSEcCtD
Hydromorphone—Confusional state—Carmustine—melanoma	0.00071	0.00175	CcSEcCtD
Hydromorphone—Arthralgia—Temozolomide—melanoma	0.00071	0.00175	CcSEcCtD
Hydromorphone—Myalgia—Temozolomide—melanoma	0.00071	0.00175	CcSEcCtD
Hydromorphone—Infestation NOS—Docetaxel—melanoma	0.00071	0.00174	CcSEcCtD
Hydromorphone—Infestation—Docetaxel—melanoma	0.00071	0.00174	CcSEcCtD
Hydromorphone—Anxiety—Temozolomide—melanoma	0.000707	0.00174	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000705	0.00173	CcSEcCtD
Hydromorphone—Discomfort—Temozolomide—melanoma	0.000701	0.00172	CcSEcCtD
Hydromorphone—Decreased appetite—Bleomycin—melanoma	0.000701	0.00172	CcSEcCtD
Hydromorphone—Infection—Carmustine—melanoma	0.0007	0.00172	CcSEcCtD
Hydromorphone—Dry mouth—Temozolomide—melanoma	0.000694	0.00171	CcSEcCtD
Hydromorphone—Stomatitis—Docetaxel—melanoma	0.000692	0.0017	CcSEcCtD
Hydromorphone—Pain—Bleomycin—melanoma	0.00069	0.0017	CcSEcCtD
Hydromorphone—Tachycardia—Carmustine—melanoma	0.000687	0.00169	CcSEcCtD
Hydromorphone—Confusional state—Temozolomide—melanoma	0.000686	0.00169	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000685	0.00169	CcSEcCtD
Hydromorphone—Anaphylactic shock—Temozolomide—melanoma	0.000681	0.00167	CcSEcCtD
Hydromorphone—Infection—Temozolomide—melanoma	0.000676	0.00166	CcSEcCtD
Hydromorphone—Anorexia—Carmustine—melanoma	0.000671	0.00165	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Docetaxel—melanoma	0.000671	0.00165	CcSEcCtD
Hydromorphone—Nervous system disorder—Temozolomide—melanoma	0.000667	0.00164	CcSEcCtD
Hydromorphone—Feeling abnormal—Bleomycin—melanoma	0.000665	0.00163	CcSEcCtD
Hydromorphone—Skin disorder—Temozolomide—melanoma	0.000661	0.00163	CcSEcCtD
Hydromorphone—Hypotension—Carmustine—melanoma	0.000658	0.00162	CcSEcCtD
Hydromorphone—Hyperhidrosis—Temozolomide—melanoma	0.000658	0.00162	CcSEcCtD
Hydromorphone—Decreased appetite—Dactinomycin—melanoma	0.000654	0.00161	CcSEcCtD
Hydromorphone—Fatigue—Dactinomycin—melanoma	0.000649	0.0016	CcSEcCtD
Hydromorphone—Anorexia—Temozolomide—melanoma	0.000649	0.0016	CcSEcCtD
Hydromorphone—Pain—Dactinomycin—melanoma	0.000643	0.00158	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Carmustine—melanoma	0.000642	0.00158	CcSEcCtD
Hydromorphone—Urticaria—Bleomycin—melanoma	0.000641	0.00158	CcSEcCtD
Hydromorphone—Rhinitis—Docetaxel—melanoma	0.000639	0.00157	CcSEcCtD
Hydromorphone—Body temperature increased—Bleomycin—melanoma	0.000638	0.00157	CcSEcCtD
Hydromorphone—Insomnia—Carmustine—melanoma	0.000637	0.00157	CcSEcCtD
Hydromorphone—Hypoaesthesia—Docetaxel—melanoma	0.000634	0.00156	CcSEcCtD
Hydromorphone—Paraesthesia—Carmustine—melanoma	0.000632	0.00155	CcSEcCtD
Hydromorphone—Urinary tract disorder—Docetaxel—melanoma	0.000629	0.00155	CcSEcCtD
Hydromorphone—Dyspnoea—Carmustine—melanoma	0.000628	0.00154	CcSEcCtD
Hydromorphone—Oedema peripheral—Docetaxel—melanoma	0.000628	0.00154	CcSEcCtD
Hydromorphone—Somnolence—Carmustine—melanoma	0.000626	0.00154	CcSEcCtD
Hydromorphone—Connective tissue disorder—Docetaxel—melanoma	0.000626	0.00154	CcSEcCtD
Hydromorphone—Urethral disorder—Docetaxel—melanoma	0.000624	0.00154	CcSEcCtD
Hydromorphone—Feeling abnormal—Dactinomycin—melanoma	0.00062	0.00152	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00062	0.00152	CcSEcCtD
Hydromorphone—Insomnia—Temozolomide—melanoma	0.000615	0.00151	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Dactinomycin—melanoma	0.000615	0.00151	CcSEcCtD
Hydromorphone—Visual impairment—Docetaxel—melanoma	0.000614	0.00151	CcSEcCtD
Hydromorphone—Decreased appetite—Carmustine—melanoma	0.000612	0.00151	CcSEcCtD
Hydromorphone—Paraesthesia—Temozolomide—melanoma	0.000611	0.0015	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Carmustine—melanoma	0.000608	0.0015	CcSEcCtD
Hydromorphone—Dyspnoea—Temozolomide—melanoma	0.000607	0.00149	CcSEcCtD
Hydromorphone—Somnolence—Temozolomide—melanoma	0.000605	0.00149	CcSEcCtD
Hydromorphone—Naloxone—ALB—melanoma	0.000605	0.0784	CrCbGaD
Hydromorphone—Pain—Carmustine—melanoma	0.000602	0.00148	CcSEcCtD
Hydromorphone—Constipation—Carmustine—melanoma	0.000602	0.00148	CcSEcCtD
Hydromorphone—Dyspepsia—Temozolomide—melanoma	0.000599	0.00147	CcSEcCtD
Hydromorphone—Eye disorder—Docetaxel—melanoma	0.000595	0.00146	CcSEcCtD
Hydromorphone—Abdominal pain—Dactinomycin—melanoma	0.000595	0.00146	CcSEcCtD
Hydromorphone—Body temperature increased—Dactinomycin—melanoma	0.000595	0.00146	CcSEcCtD
Hydromorphone—Hypersensitivity—Bleomycin—melanoma	0.000594	0.00146	CcSEcCtD
Hydromorphone—Decreased appetite—Temozolomide—melanoma	0.000592	0.00145	CcSEcCtD
Hydromorphone—Flushing—Docetaxel—melanoma	0.000591	0.00145	CcSEcCtD
Hydromorphone—Cardiac disorder—Docetaxel—melanoma	0.000591	0.00145	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Temozolomide—melanoma	0.000588	0.00144	CcSEcCtD
Hydromorphone—Fatigue—Temozolomide—melanoma	0.000587	0.00144	CcSEcCtD
Hydromorphone—Pain—Temozolomide—melanoma	0.000582	0.00143	CcSEcCtD
Hydromorphone—Constipation—Temozolomide—melanoma	0.000582	0.00143	CcSEcCtD
Hydromorphone—Feeling abnormal—Carmustine—melanoma	0.00058	0.00143	CcSEcCtD
Hydromorphone—Asthenia—Bleomycin—melanoma	0.000579	0.00142	CcSEcCtD
Hydromorphone—Angiopathy—Docetaxel—melanoma	0.000578	0.00142	CcSEcCtD
Hydromorphone—Naloxone—ABCB1—melanoma	0.000577	0.0748	CrCbGaD
Hydromorphone—Gastrointestinal pain—Carmustine—melanoma	0.000576	0.00142	CcSEcCtD
Hydromorphone—Immune system disorder—Docetaxel—melanoma	0.000575	0.00141	CcSEcCtD
Hydromorphone—Mediastinal disorder—Docetaxel—melanoma	0.000574	0.00141	CcSEcCtD
Hydromorphone—Chills—Docetaxel—melanoma	0.000572	0.00141	CcSEcCtD
Hydromorphone—Pruritus—Bleomycin—melanoma	0.000571	0.0014	CcSEcCtD
Hydromorphone—Arrhythmia—Docetaxel—melanoma	0.000569	0.0014	CcSEcCtD
Hydromorphone—Feeling abnormal—Temozolomide—melanoma	0.000561	0.00138	CcSEcCtD
Hydromorphone—Mental disorder—Docetaxel—melanoma	0.000558	0.00137	CcSEcCtD
Hydromorphone—Body temperature increased—Carmustine—melanoma	0.000557	0.00137	CcSEcCtD
Hydromorphone—Abdominal pain—Carmustine—melanoma	0.000557	0.00137	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Temozolomide—melanoma	0.000556	0.00137	CcSEcCtD
Hydromorphone—Erythema—Docetaxel—melanoma	0.000555	0.00136	CcSEcCtD
Hydromorphone—Malnutrition—Docetaxel—melanoma	0.000555	0.00136	CcSEcCtD
Hydromorphone—Hypersensitivity—Dactinomycin—melanoma	0.000554	0.00136	CcSEcCtD
Hydromorphone—Dysgeusia—Docetaxel—melanoma	0.000543	0.00134	CcSEcCtD
Hydromorphone—Urticaria—Temozolomide—melanoma	0.000541	0.00133	CcSEcCtD
Hydromorphone—Asthenia—Dactinomycin—melanoma	0.00054	0.00133	CcSEcCtD
Hydromorphone—Abdominal pain—Temozolomide—melanoma	0.000538	0.00132	CcSEcCtD
Hydromorphone—Body temperature increased—Temozolomide—melanoma	0.000538	0.00132	CcSEcCtD
Hydromorphone—Back pain—Docetaxel—melanoma	0.000536	0.00132	CcSEcCtD
Hydromorphone—Muscle spasms—Docetaxel—melanoma	0.000533	0.00131	CcSEcCtD
Hydromorphone—Hypersensitivity—Carmustine—melanoma	0.000519	0.00128	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—melanoma	0.000515	0.00127	CcSEcCtD
Hydromorphone—Vomiting—Bleomycin—melanoma	0.000513	0.00126	CcSEcCtD
Hydromorphone—Rash—Bleomycin—melanoma	0.000509	0.00125	CcSEcCtD
Hydromorphone—Dermatitis—Bleomycin—melanoma	0.000508	0.00125	CcSEcCtD
Hydromorphone—Asthenia—Carmustine—melanoma	0.000505	0.00124	CcSEcCtD
Hydromorphone—Hypersensitivity—Temozolomide—melanoma	0.000501	0.00123	CcSEcCtD
Hydromorphone—Syncope—Docetaxel—melanoma	0.000497	0.00122	CcSEcCtD
Hydromorphone—Leukopenia—Docetaxel—melanoma	0.000496	0.00122	CcSEcCtD
Hydromorphone—Palpitations—Docetaxel—melanoma	0.00049	0.00121	CcSEcCtD
Hydromorphone—Asthenia—Temozolomide—melanoma	0.000488	0.0012	CcSEcCtD
Hydromorphone—Loss of consciousness—Docetaxel—melanoma	0.000487	0.0012	CcSEcCtD
Hydromorphone—Morphine—ABCB1—melanoma	0.000487	0.0632	CrCbGaD
Hydromorphone—Cough—Docetaxel—melanoma	0.000484	0.00119	CcSEcCtD
Hydromorphone—Diarrhoea—Carmustine—melanoma	0.000482	0.00118	CcSEcCtD
Hydromorphone—Pruritus—Temozolomide—melanoma	0.000481	0.00118	CcSEcCtD
Hydromorphone—Convulsion—Docetaxel—melanoma	0.00048	0.00118	CcSEcCtD
Hydromorphone—Nausea—Bleomycin—melanoma	0.000479	0.00118	CcSEcCtD
Hydromorphone—Hypertension—Docetaxel—melanoma	0.000479	0.00118	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—melanoma	0.000478	0.00118	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—melanoma	0.000474	0.00117	CcSEcCtD
Hydromorphone—Chest pain—Docetaxel—melanoma	0.000472	0.00116	CcSEcCtD
Hydromorphone—Arthralgia—Docetaxel—melanoma	0.000472	0.00116	CcSEcCtD
Hydromorphone—Myalgia—Docetaxel—melanoma	0.000472	0.00116	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000469	0.00115	CcSEcCtD
Hydromorphone—Dizziness—Carmustine—melanoma	0.000466	0.00115	CcSEcCtD
Hydromorphone—Diarrhoea—Temozolomide—melanoma	0.000466	0.00115	CcSEcCtD
Hydromorphone—Dry mouth—Docetaxel—melanoma	0.000462	0.00114	CcSEcCtD
Hydromorphone—Confusional state—Docetaxel—melanoma	0.000456	0.00112	CcSEcCtD
Hydromorphone—Anaphylactic shock—Docetaxel—melanoma	0.000453	0.00111	CcSEcCtD
Hydromorphone—Dizziness—Temozolomide—melanoma	0.00045	0.00111	CcSEcCtD
Hydromorphone—Infection—Docetaxel—melanoma	0.00045	0.00111	CcSEcCtD
Hydromorphone—Vomiting—Carmustine—melanoma	0.000448	0.0011	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—melanoma	0.000447	0.0011	CcSEcCtD
Hydromorphone—Shock—Docetaxel—melanoma	0.000445	0.00109	CcSEcCtD
Hydromorphone—Rash—Carmustine—melanoma	0.000444	0.00109	CcSEcCtD
Hydromorphone—Nervous system disorder—Docetaxel—melanoma	0.000444	0.00109	CcSEcCtD
Hydromorphone—Dermatitis—Carmustine—melanoma	0.000444	0.00109	CcSEcCtD
Hydromorphone—Tachycardia—Docetaxel—melanoma	0.000442	0.00109	CcSEcCtD
Hydromorphone—Headache—Carmustine—melanoma	0.000441	0.00108	CcSEcCtD
Hydromorphone—Skin disorder—Docetaxel—melanoma	0.00044	0.00108	CcSEcCtD
Hydromorphone—Vomiting—Temozolomide—melanoma	0.000433	0.00106	CcSEcCtD
Hydromorphone—Anorexia—Docetaxel—melanoma	0.000431	0.00106	CcSEcCtD
Hydromorphone—Rash—Temozolomide—melanoma	0.000429	0.00106	CcSEcCtD
Hydromorphone—Dermatitis—Temozolomide—melanoma	0.000429	0.00105	CcSEcCtD
Hydromorphone—Headache—Temozolomide—melanoma	0.000426	0.00105	CcSEcCtD
Hydromorphone—Hypotension—Docetaxel—melanoma	0.000423	0.00104	CcSEcCtD
Hydromorphone—Nausea—Carmustine—melanoma	0.000418	0.00103	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000412	0.00101	CcSEcCtD
Hydromorphone—Insomnia—Docetaxel—melanoma	0.000409	0.00101	CcSEcCtD
Hydromorphone—Dextromethorphan—ABCB1—melanoma	0.000409	0.053	CrCbGaD
Hydromorphone—Paraesthesia—Docetaxel—melanoma	0.000406	0.000999	CcSEcCtD
Hydromorphone—Nausea—Temozolomide—melanoma	0.000404	0.000994	CcSEcCtD
Hydromorphone—Dyspnoea—Docetaxel—melanoma	0.000403	0.000992	CcSEcCtD
Hydromorphone—Somnolence—Docetaxel—melanoma	0.000402	0.000989	CcSEcCtD
Hydromorphone—Dyspepsia—Docetaxel—melanoma	0.000398	0.00098	CcSEcCtD
Hydromorphone—Decreased appetite—Docetaxel—melanoma	0.000393	0.000967	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Docetaxel—melanoma	0.000391	0.000961	CcSEcCtD
Hydromorphone—Fatigue—Docetaxel—melanoma	0.00039	0.000959	CcSEcCtD
Hydromorphone—Pain—Docetaxel—melanoma	0.000387	0.000952	CcSEcCtD
Hydromorphone—Constipation—Docetaxel—melanoma	0.000387	0.000952	CcSEcCtD
Hydromorphone—Feeling abnormal—Docetaxel—melanoma	0.000373	0.000917	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Docetaxel—melanoma	0.00037	0.00091	CcSEcCtD
Hydromorphone—Abdominal pain—Docetaxel—melanoma	0.000358	0.00088	CcSEcCtD
Hydromorphone—Body temperature increased—Docetaxel—melanoma	0.000358	0.00088	CcSEcCtD
Hydromorphone—Hypersensitivity—Docetaxel—melanoma	0.000333	0.00082	CcSEcCtD
Hydromorphone—Asthenia—Docetaxel—melanoma	0.000325	0.000798	CcSEcCtD
Hydromorphone—Pruritus—Docetaxel—melanoma	0.00032	0.000787	CcSEcCtD
Hydromorphone—Diarrhoea—Docetaxel—melanoma	0.00031	0.000761	CcSEcCtD
Hydromorphone—Dizziness—Docetaxel—melanoma	0.000299	0.000736	CcSEcCtD
Hydromorphone—Vomiting—Docetaxel—melanoma	0.000288	0.000708	CcSEcCtD
Hydromorphone—Rash—Docetaxel—melanoma	0.000285	0.000702	CcSEcCtD
Hydromorphone—Dermatitis—Docetaxel—melanoma	0.000285	0.000701	CcSEcCtD
Hydromorphone—Headache—Docetaxel—melanoma	0.000284	0.000697	CcSEcCtD
Hydromorphone—Nausea—Docetaxel—melanoma	0.000269	0.000661	CcSEcCtD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK3—melanoma	3.56e-05	0.000148	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDGFRA—melanoma	3.56e-05	0.000147	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KDR—melanoma	3.54e-05	0.000147	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.54e-05	0.000146	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ITGB3—melanoma	3.52e-05	0.000146	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKCA—melanoma	3.52e-05	0.000146	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PRKCA—melanoma	3.51e-05	0.000145	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—BRAF—melanoma	3.5e-05	0.000145	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ERCC2—melanoma	3.48e-05	0.000144	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—VCAN—melanoma	3.46e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SPP1—melanoma	3.45e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAP2K2—melanoma	3.44e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL8—melanoma	3.44e-05	0.000142	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—VCAN—melanoma	3.43e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FN1—melanoma	3.41e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF1—melanoma	3.41e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK1—melanoma	3.39e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—melanoma	3.39e-05	0.00014	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CG—melanoma	3.37e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH1—melanoma	3.34e-05	0.000138	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAP2K1—melanoma	3.29e-05	0.000136	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PHGDH—melanoma	3.29e-05	0.000136	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LUM—melanoma	3.29e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—melanoma	3.28e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TERT—melanoma	3.27e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CD—melanoma	3.27e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CD80—melanoma	3.27e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAC1—melanoma	3.26e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CG—melanoma	3.26e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APC—melanoma	3.26e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KIT—melanoma	3.26e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—NRAS—melanoma	3.26e-05	0.000135	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARG—melanoma	3.25e-05	0.000135	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.25e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	3.24e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGF—melanoma	3.23e-05	0.000134	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HPSE—melanoma	3.22e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KRAS—melanoma	3.2e-05	0.000133	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CUBN—melanoma	3.17e-05	0.000131	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.13e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGF2—melanoma	3.13e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIF1A—melanoma	3.13e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK3—melanoma	3.12e-05	0.000129	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BRAF—melanoma	3.07e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CSPG4—melanoma	3.06e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDHD—melanoma	3.06e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BSG—melanoma	3.06e-05	0.000127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—melanoma	2.99e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1—melanoma	2.99e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK1—melanoma	2.97e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—melanoma	2.97e-05	0.000123	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CD—melanoma	2.96e-05	0.000123	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPAM—melanoma	2.96e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—melanoma	2.94e-05	0.000122	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MDM2—melanoma	2.93e-05	0.000121	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—melanoma	2.93e-05	0.000121	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP17A1—melanoma	2.92e-05	0.000121	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP17A1—melanoma	2.89e-05	0.00012	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB2—melanoma	2.89e-05	0.00012	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAP2K1—melanoma	2.89e-05	0.00012	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.88e-05	0.000119	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FN1—melanoma	2.88e-05	0.000119	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CD—melanoma	2.87e-05	0.000119	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.85e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CB—melanoma	2.85e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	2.84e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH1—melanoma	2.82e-05	0.000117	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.82e-05	0.000117	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KRAS—melanoma	2.81e-05	0.000116	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CD80—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APC—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CG—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KIT—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—NRAS—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GNA11—melanoma	2.76e-05	0.000114	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CG—melanoma	2.75e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGF2—melanoma	2.75e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—melanoma	2.74e-05	0.000113	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GNA11—melanoma	2.73e-05	0.000113	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGF—melanoma	2.73e-05	0.000113	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—melanoma	2.72e-05	0.000113	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—FASN—melanoma	2.7e-05	0.000112	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1B—melanoma	2.68e-05	0.000111	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—FASN—melanoma	2.67e-05	0.000111	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—melanoma	2.65e-05	0.00011	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC5A5—melanoma	2.65e-05	0.00011	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—melanoma	2.65e-05	0.00011	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—melanoma	2.64e-05	0.000109	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC5A5—melanoma	2.63e-05	0.000109	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—melanoma	2.62e-05	0.000109	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—melanoma	2.62e-05	0.000108	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—melanoma	2.61e-05	0.000108	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—melanoma	2.59e-05	0.000107	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CB—melanoma	2.58e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—melanoma	2.58e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MDM2—melanoma	2.57e-05	0.000106	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GNAQ—melanoma	2.56e-05	0.000106	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD44—melanoma	2.56e-05	0.000106	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—melanoma	2.56e-05	0.000106	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—melanoma	2.55e-05	0.000106	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD44—melanoma	2.54e-05	0.000105	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GNAQ—melanoma	2.54e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—melanoma	2.53e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—melanoma	2.53e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—melanoma	2.52e-05	0.000105	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G6—melanoma	2.52e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK1—melanoma	2.51e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—melanoma	2.51e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CB—melanoma	2.5e-05	0.000104	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.49e-05	0.000103	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—melanoma	2.48e-05	0.000103	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—melanoma	2.47e-05	0.000102	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.46e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—melanoma	2.46e-05	0.000102	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1B1—melanoma	2.46e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NFKB1—melanoma	2.45e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAP2K1—melanoma	2.44e-05	0.000101	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1B1—melanoma	2.43e-05	0.000101	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CD—melanoma	2.42e-05	0.0001	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CD—melanoma	2.42e-05	0.0001	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—melanoma	2.4e-05	9.95e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—melanoma	2.4e-05	9.95e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	2.4e-05	9.94e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—melanoma	2.39e-05	9.88e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—melanoma	2.39e-05	9.88e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—melanoma	2.37e-05	9.83e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1B—melanoma	2.35e-05	9.71e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGF2—melanoma	2.32e-05	9.61e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—melanoma	2.32e-05	9.61e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—melanoma	2.3e-05	9.52e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—melanoma	2.3e-05	9.51e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—melanoma	2.28e-05	9.46e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—VCAN—melanoma	2.26e-05	9.36e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—melanoma	2.24e-05	9.27e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—melanoma	2.23e-05	9.25e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—melanoma	2.23e-05	9.21e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—melanoma	2.22e-05	9.18e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—melanoma	2.2e-05	9.12e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NRAS—melanoma	2.2e-05	9.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—melanoma	2.18e-05	9.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—melanoma	2.17e-05	9e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MDM2—melanoma	2.17e-05	8.99e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—melanoma	2.17e-05	8.97e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—melanoma	2.16e-05	8.95e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NFKB1—melanoma	2.15e-05	8.9e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.15e-05	8.9e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—melanoma	2.14e-05	8.87e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CB—melanoma	2.11e-05	8.75e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—melanoma	2.11e-05	8.73e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CB—melanoma	2.11e-05	8.72e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—melanoma	2.11e-05	8.72e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—melanoma	2.09e-05	8.64e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—melanoma	2.05e-05	8.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—melanoma	2.03e-05	8.41e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—melanoma	2.02e-05	8.37e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—melanoma	2.02e-05	8.35e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—melanoma	2.01e-05	8.3e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK1—melanoma	2e-05	8.29e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—melanoma	2e-05	8.29e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1B—melanoma	1.98e-05	8.21e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—melanoma	1.96e-05	8.12e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—melanoma	1.95e-05	8.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—melanoma	1.94e-05	8.05e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—melanoma	1.94e-05	8.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—melanoma	1.93e-05	8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—melanoma	1.93e-05	7.99e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NRAS—melanoma	1.93e-05	7.98e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP17A1—melanoma	1.91e-05	7.9e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—melanoma	1.89e-05	7.83e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—melanoma	1.89e-05	7.83e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—melanoma	1.87e-05	7.76e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PRKCA—melanoma	1.86e-05	7.71e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ERCC2—melanoma	1.85e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—melanoma	1.85e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PRKCA—melanoma	1.85e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—melanoma	1.84e-05	7.6e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ERCC2—melanoma	1.83e-05	7.58e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—melanoma	1.83e-05	7.58e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—melanoma	1.83e-05	7.56e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—melanoma	1.82e-05	7.54e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKB1—melanoma	1.82e-05	7.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GNA11—melanoma	1.8e-05	7.46e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—melanoma	1.8e-05	7.43e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—melanoma	1.78e-05	7.38e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—FASN—melanoma	1.76e-05	7.3e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK1—melanoma	1.76e-05	7.27e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—melanoma	1.76e-05	7.27e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—melanoma	1.74e-05	7.2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC5A5—melanoma	1.73e-05	7.18e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—melanoma	1.68e-05	6.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GNAQ—melanoma	1.67e-05	6.93e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD44—melanoma	1.67e-05	6.93e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—melanoma	1.66e-05	6.87e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—melanoma	1.65e-05	6.83e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—melanoma	1.63e-05	6.76e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NRAS—melanoma	1.63e-05	6.74e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—melanoma	1.61e-05	6.66e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1B1—melanoma	1.61e-05	6.65e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—melanoma	1.58e-05	6.52e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—melanoma	1.56e-05	6.46e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—melanoma	1.54e-05	6.37e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—melanoma	1.52e-05	6.31e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—melanoma	1.52e-05	6.28e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.52e-05	6.28e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK1—melanoma	1.48e-05	6.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—melanoma	1.48e-05	6.15e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—melanoma	1.47e-05	6.1e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—melanoma	1.46e-05	6.04e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—melanoma	1.45e-05	5.98e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—melanoma	1.42e-05	5.88e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—melanoma	1.41e-05	5.84e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—melanoma	1.41e-05	5.83e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—melanoma	1.4e-05	5.81e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—melanoma	1.39e-05	5.78e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—melanoma	1.35e-05	5.59e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—melanoma	1.32e-05	5.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—melanoma	1.29e-05	5.33e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—melanoma	1.29e-05	5.33e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—melanoma	1.28e-05	5.32e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CD—melanoma	1.28e-05	5.31e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CD—melanoma	1.27e-05	5.26e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—melanoma	1.27e-05	5.24e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—melanoma	1.25e-05	5.19e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—melanoma	1.25e-05	5.16e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—melanoma	1.25e-05	5.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PRKCA—melanoma	1.22e-05	5.04e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ERCC2—melanoma	1.21e-05	5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—melanoma	1.19e-05	4.93e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—melanoma	1.14e-05	4.72e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CB—melanoma	1.12e-05	4.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CB—melanoma	1.11e-05	4.59e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—melanoma	1.11e-05	4.58e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—melanoma	1.1e-05	4.54e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—melanoma	1.05e-05	4.36e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—melanoma	1.05e-05	4.34e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—melanoma	9.65e-06	4e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—melanoma	9.57e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—melanoma	9.53e-06	3.95e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—melanoma	9.2e-06	3.81e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CD—melanoma	8.38e-06	3.47e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—melanoma	8.27e-06	3.43e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CB—melanoma	7.3e-06	3.02e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—melanoma	7.24e-06	3e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—melanoma	6.81e-06	2.82e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—melanoma	6.75e-06	2.8e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—melanoma	6.31e-06	2.61e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—melanoma	5.56e-06	2.3e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—melanoma	5.52e-06	2.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—melanoma	4.45e-06	1.84e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—melanoma	3.64e-06	1.51e-05	CbGpPWpGaD
